Lei Huang

5.4k total citations
79 papers, 4.0k citations indexed

About

Lei Huang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lei Huang has authored 79 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 25 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Lei Huang's work include Immune Cell Function and Interaction (26 papers), Tryptophan and brain disorders (18 papers) and Immunotherapy and Immune Responses (13 papers). Lei Huang is often cited by papers focused on Immune Cell Function and Interaction (26 papers), Tryptophan and brain disorders (18 papers) and Immunotherapy and Immune Responses (13 papers). Lei Huang collaborates with scholars based in United States, China and United Kingdom. Lei Huang's co-authors include Andrew L. Mellor, Henrique Lemos, Demetrius Moskophidis, Rong Ou, Nahid F. Mivechi, David H. Munn, Shenghua Zhou, George C. Prendergast, Tracy L. McGaha and Gabriela Pacholczyk and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Nature reviews. Cancer.

In The Last Decade

Lei Huang

78 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Huang United States 33 2.0k 1.6k 844 500 444 79 4.0k
Pandelakis A. Koni United States 43 4.6k 2.3× 2.4k 1.5× 1.4k 1.6× 788 1.6× 456 1.0× 63 7.8k
Eun Young Choi South Korea 35 1.7k 0.8× 2.5k 1.6× 673 0.8× 289 0.6× 559 1.3× 175 5.3k
Réjean Lapointe Canada 30 2.1k 1.1× 1.0k 0.6× 1.2k 1.4× 560 1.1× 221 0.5× 80 4.0k
Kristoffer Hellstrand Sweden 44 2.8k 1.4× 1.2k 0.8× 830 1.0× 212 0.4× 223 0.5× 187 5.7k
Stefanie Scheu Germany 33 2.5k 1.3× 662 0.4× 586 0.7× 191 0.4× 154 0.3× 61 3.8k
Tadahiko Kohno United States 28 1.4k 0.7× 1.2k 0.8× 423 0.5× 201 0.4× 311 0.7× 46 3.6k
Günther Böck Austria 29 1.9k 0.9× 1.9k 1.2× 953 1.1× 107 0.2× 334 0.8× 66 4.1k
Sachiko Miyake Japan 56 5.8k 2.9× 3.1k 2.0× 1.4k 1.7× 384 0.8× 258 0.6× 152 10.0k
Daniel E. Tracey United States 25 2.6k 1.3× 2.1k 1.4× 506 0.6× 142 0.3× 237 0.5× 50 5.4k
Stephen M. Baird United States 25 1.8k 0.9× 1.5k 1.0× 776 0.9× 97 0.2× 352 0.8× 71 4.5k

Countries citing papers authored by Lei Huang

Since Specialization
Citations

This map shows the geographic impact of Lei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Huang more than expected).

Fields of papers citing papers by Lei Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Huang. The network helps show where Lei Huang may publish in the future.

Co-authorship network of co-authors of Lei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Huang. A scholar is included among the top collaborators of Lei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Huang. Lei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chenglin, Yanyan Liu, Haoran Guo, et al.. (2025). Interleukin 21-Armed EGFR-VHH-CAR-T Cell Therapy for the Treatment of Esophageal Squamous Cell Carcinoma. Biomedicines. 13(7). 1598–1598.
3.
Wan, Sheng, Hui Shen, Shan Zhang, et al.. (2022). Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis. Journal of Medicinal Chemistry. 65(21). 14348–14365. 12 indexed citations
4.
Wu, Yongxia, Chih-Hang Anthony Tang, David Bastian, et al.. (2021). STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function. Cellular and Molecular Immunology. 18(3). 632–643. 5 indexed citations
5.
Colombo, Rhonda E, Maribeth H. Johnson, Gabriela Pacholczyk, et al.. (2021). Indoleamine 2,3 Dioxygenase, Age, and Immune Activation in People Living with Hiv. Journal of Investigative Medicine. 69(6). 1238–1244. 7 indexed citations
6.
Zhou, Chenfei, Yanmei Zhang, Rui-Ming Yan, et al.. (2020). Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment. Cell Death and Differentiation. 28(2). 715–729. 77 indexed citations
7.
Yu, Miao, Gang Guo, Lei Huang, et al.. (2020). CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nature Communications. 11(1). 515–515. 141 indexed citations
8.
Lemos, Henrique, Rong Ou, Yijun Lin, et al.. (2020). Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity. Journal for ImmunoTherapy of Cancer. 8(2). e001182–e001182. 50 indexed citations
9.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2019). A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease. Clinical Cancer Research. 26(1). 282–289. 22 indexed citations
10.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2018). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. PMC. 1 indexed citations
11.
Zhou, Chenfei, Jing Ma, Lei Huang, et al.. (2018). Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 38(8). 1256–1268. 160 indexed citations
12.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2017). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. Cancer Research. 78(3). 809–816. 54 indexed citations
13.
Wu, Sha, Wei Zhu, Yibing Peng, et al.. (2017). The Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells. Cancer Immunology Research. 5(10). 908–919. 23 indexed citations
14.
Lemos, Henrique, Eslam Mohamed, Lei Huang, et al.. (2016). STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation. Cancer Research. 76(8). 2076–2081. 251 indexed citations
15.
Qi, Meng, Lei Huang, Rongjun Wang, et al.. (2014). Natural infection of Cryptosporidium muris in ostriches (Struthio camelus). Veterinary Parasitology. 205(3-4). 518–522. 24 indexed citations
16.
Liu, Rui, Lei Huang, Jingyi Li, et al.. (2013). HIV Infection in Gastric Epithelial Cells. The Journal of Infectious Diseases. 208(8). 1221–1230. 19 indexed citations
17.
Li, Qizhang, et al.. (2010). Fungal immunomodulatory protein from Ganoderma sinense expressed in E. coli and the identification of immunocompetence.. Xibei zhiwu xuebao. 30(1). 35–40. 2 indexed citations
18.
Ou, Rong, Menghua Zhang, Lei Huang, & Demetrius Moskophidis. (2008). Control of Virus-Specific CD8+T-Cell Exhaustion and Immune-Mediated Pathology by E3 Ubiquitin Ligase Cbl-b during Chronic Viral Infection. Journal of Virology. 82(7). 3353–3368. 31 indexed citations
19.
Lipan, Ovidiu, et al.. (2007). Heat Shock Response in CHO Mammalian Cells Is Controlled by a Nonlinear Stochastic Process. PLoS Computational Biology. 3(10). e187–e187. 11 indexed citations
20.
Zhou, Shenghua, Rong Ou, Lei Huang, Graeme E. Price, & Demetrius Moskophidis. (2004). Differential Tissue-Specific Regulation of Antiviral CD8+T-Cell Immune Responses during Chronic Viral Infection. Journal of Virology. 78(7). 3578–3600. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026